TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis

P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies

(2009) Zhizhong Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer

(2009) Katie A. Ashton et al.   GYNECOLOGIC ONCOLOGY

Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer

(2009) Osamu NUNOBIKI et al.   Human Cell

P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case–control studies

(2009) Shengming Dai et al.   HUMAN GENETICS

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies

(2009) Stefanie J Klug et al.   LANCET ONCOLOGY

The p53 Codon 72 Exon 4 BstUI Polymorphism and Endometrial Cancer in Caucasian Women

(2009) Pavol Zubor et al.   ONCOLOGY

Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: A clinical review

(2008) Andrea Tinelli et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Endometrial hyperplasia, endometrial cancer and prevention: Gaps in existing research of modifiable risk factors

(2008) Faina Linkov et al.   EUROPEAN JOURNAL OF CANCER

Genetic polymorphisms and endometrial cancer risk

(2008) Larissa A Meyer et al.   Expert Review of Anticancer Therapy

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias

(2008) Kerry Dwan et al.   PLoS One